Denise Madeddu

Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

Giulia Mazzaschi, Denise Madeddu, Angela Falco et al. · Clinical Cancer Research · 2017 · 259 citations

Medicine, Immunology, Oncology +17

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale et al. · Lung Cancer · 2018 · 136 citations

Life Sciences, Immunology, Oncology +17

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells

Mara Bonelli, Graziana Digiacomo, Claudia Fumarola et al. · Neoplasia · 2017 · 105 citations · Full text

Medicine, Oncology, Pharmacology +17

Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application

Ranjana Rai, Marwa Tallawi, Niccoletta Barbani et al. · Materials Science and Engineering C · 2013 · 104 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR- Activating Mutation

Silvia La Monica, Denise Madeddu, Marcello Tiseo et al. · Journal of Thoracic Oncology · 2016 · 79 citations

Medicine, Molecular Biology, Oncology +13